Watanabe Chizuko, Okuda Kazuhiro, Sakurada Chikai, Ando Ryuichiro, Sakurada Tsukasa, Sakurada Shinobu
Center for Laboratory Animal Science, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
Brain Res. 2003 Nov 14;990(1-2):77-86. doi: 10.1016/s0006-8993(03)03440-1.
We evaluated the ability of spinally administered nitric oxide (NO) synthase inhibitor to modulate antinociceptive action of intrathecal (i.t.) morphine in rats by measuring the early and late phases of flinching and licking/biting in the formalin test. To determine the contribution of spinal NO and glutamate, we measured the release of NO metabolites (nitrite/nitrate) and glutamate from the spinal cord in rats, using a microdialysis probe placed in the lumbar space. The i.t. administration of NG-nitro L-arginine methyl ester (L-NAME) produced a dose-dependent reduction in the number of flinches during the late phase, whereas there were no significant alterations in the late phase licking/biting, and early phase flinching and licking/biting. Spinal administration of morphine at low doses produced a significant antinociceptive activity in the early and late phases of the flinching behaviour, whereas higher doses of morphine were required to obtain a significant effect in the licking/biting behaviour during both phases. Combination of L-NAME with morphine resulted in an enhanced reduction in the early and late phase flinching. Enhanced antinociceptive activity was observed in the late phase licking/biting by i.t. combined administration of L-NAME (400 nmol) and morphine (1.25 nmol). In the present study, we have confirmed our prior results that injection of formalin (5.0%) into the plantar surface of the paw evoked a biphasic spinal release of nitrite/nitrate and a transient release of glutamate. Formalin-evoked release of nitrite/nitrate and glutamate was also reduced markedly by i.t. combined administration of L-NAME and morphine. These behavioural and biochemical results suggest that i.t. administered L-NAME may enhance morphine-induced antinociception through an increased inhibition of nitrite/nitrate and glutamate releases evoked by formalin injection at the spinal cord level.
我们通过测量福尔马林试验中大鼠的早期和晚期退缩及舔咬/啃咬行为,评估了脊髓给予一氧化氮(NO)合酶抑制剂对鞘内(i.t.)吗啡镇痛作用的调节能力。为了确定脊髓中NO和谷氨酸的作用,我们使用置于腰段的微透析探针,测量了大鼠脊髓中NO代谢产物(亚硝酸盐/硝酸盐)和谷氨酸的释放。i.t.给予NG-硝基-L-精氨酸甲酯(L-NAME)可使晚期退缩次数呈剂量依赖性减少,而晚期舔咬/啃咬以及早期退缩和舔咬/啃咬均无显著变化。低剂量脊髓给予吗啡在退缩行为的早期和晚期产生显著的镇痛活性,而在两个阶段的舔咬/啃咬行为中则需要更高剂量的吗啡才能获得显著效果。L-NAME与吗啡联合使用导致早期和晚期退缩的减少增强。i.t.联合给予L-NAME(400 nmol)和吗啡(1.25 nmol)可观察到晚期舔咬/啃咬行为的镇痛活性增强。在本研究中,我们证实了之前的结果,即向爪足底表面注射福尔马林(5.0%)可引起脊髓中亚硝酸盐/硝酸盐的双相释放和谷氨酸的短暂释放。L-NAME和吗啡联合i.t.给药也可显著减少福尔马林引起的亚硝酸盐/硝酸盐和谷氨酸释放。这些行为学和生物化学结果表明,i.t.给予L-NAME可能通过增强对脊髓水平福尔马林注射引起的亚硝酸盐/硝酸盐和谷氨酸释放的抑制作用来增强吗啡诱导的镇痛作用。